Drug intelligence / Profile preview

HT008

Development stage
Unknown
Lead developer
NeuMed Biotechnology
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

HT008 is a standardized botanical extract developed by Neumed for the improvement of joint health and the management of osteoarthritis symptoms. It is a complex mixture derived from three medicinal herbs: *Eleutherococcus senticosus* (Siberian ginseng), *Achyranthes bidentata*, and *Phlomis umbrosa*. The extract exerts its therapeutic effects through multiple anti-inflammatory and chondroprotective pathways. Specifically, it inhibits the production of pro-inflammatory mediators such as prostaglandin E2 (PGE2) and cytokines including interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α). Furthermore, HT008 helps preserve joint integrity by suppressing the expression of matrix metalloproteinases (MMPs), such as MMP-1, MMP-3, and MMP-13, which are responsible for the degradation of the articular cartilage extracellular matrix. In South Korea, HT008 has been recognized by the Ministry of Food and Drug Safety (MFDS) as a functional ingredient for joint health.

Other names
Eleutherococcus senticosus, Achyranthes bidentata, and Phlomis umbrosa extract
02

Targets

MMP3 (Matrix metalloproteinase-3)MMP13 (Matrix metalloproteinase-13)MMP1 (Matrix metalloproteinase-1)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on HT008.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HT008.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call